Awake at the wheel: Jazz buys Sumitomo sleep disorder candidate in $1.59B deal | BioWorld

Retrieved on: 2022-05-05 21:53:16

Tags for this article:

Click the tags to see associated articles and topics

Awake at the wheel: Jazz buys Sumitomo sleep disorder candidate in $1.59B deal | BioWorld. View article details on hiswai:

Excerpt

In late March, Dublin-based Jazz sold Sunosi (solriamfetol) for treating narcolepsy or obstructive sleep apnea to Axsome Therapeutics Inc., ...

Article found on: www.bioworld.com